Core Cap Advisors, LLC Novartis Ag Transaction History
Core Cap Advisors, LLC
- $2.18 Billion
- Q1 2025
A detailed history of Core Cap Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Core Cap Advisors, LLC holds 1,350 shares of NVS stock, worth $152,833. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,350
Previous 2,079
35.06%
Holding current value
$152,833
Previous $202,000
25.74%
% of portfolio
0.01%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding NVS
# of Institutions
1,523Shares Held
142MCall Options Held
1.63MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA11.8MShares$1.34 Billion0.81% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.18 Billion0.98% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.61MShares$974 Million0.25% of portfolio
-
Morgan Stanley New York, NY7.06MShares$799 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa6.76MShares$766 Million0.33% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $244B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...